Search Results for: blood sugar

New Research Reveals Link Between High Blood Sugar and Upper Limb Problems

Posted on 16, January 2024 by

(IN BRIEF) A recent study led by the University of Exeter has identified a connection between consistently high blood sugar levels and upper limb conditions such as frozen shoulder, Dupuytren’s disease, carpal tunnel syndrome, and trigger finger. The research, conducted … Read the full press release →

Posted in Business, Education, Healthcare, Industrial, Management, News, Science, United Kingdom

Tagged , , , , , , , , ,

Sanofi’s investigational therapy Toujeo® consistently showed significantly fewer low blood sugar events compared with Lantus®

Posted on 16, June 2014 by

Meta-analysis of three late-stage trials in people with type 2 diabetes shows decreases in risk of low blood sugar events of up to 31% at night-time compared with Lantus® All studies in the phase 3 “EDITION” clinical trial program, including a … Read the full press release →

Posted in France, Healthcare, Pharma & Biotech

Tagged , , , ,

Beiersdorf Unveils Breakthrough Anti-Glycation Ingredient to Combat Sugar-Induced Skin Aging

Posted on 23, April 2024 by

(IN BRIEF) After nearly a decade of research, Beiersdorf has revealed a groundbreaking discovery in skincare: a patented active ingredient called NAHP, also known as GLYCOSTOP™, designed to counteract the skin’s glycation process induced by sugar consumption, which contributes to … Read the full press release →

Posted in Apparel, Fashion & Beauty, Business, Environment, Financial, Germany, Healthcare, Industrial, Investment, Management, News, Science, Technology

Tagged , , , , , , ,

Boehringer Ingelheim: Phase III clinical trial found that empagliflozin in combination with metformin reduces blood glucose levels in adults with type 2 diabetes

Posted on 8, June 2015 by

Initial combinations of empagliflozin and metformin in patients with T2D led to significant reductions in blood glucose vs. empagliflozin or metformin alone at 24 weeks Ingelheim, Germany and Indianapolis, US, 8-6-2015 — /EuropaWire/ — A Phase III clinical trial has … Read the full press release →

Posted in Germany, Healthcare, Pharma & Biotech, Science

Tagged , , , , ,

Thales Adaptive Connect (TAC) Transforms IoT Connectivity with Eseye Partnership

Posted on 28, February 2024 by

(IN BRIEF) Eseye, a global IoT connectivity solutions provider, has partnered with Thales to enhance IoT devices’ connectivity. They are leveraging Thales’ expertise to implement Thales Adaptive Connect (TAC), a cloud-based solution based on eSIM technology. This solution eliminates the … Read the full press release →

Posted in Business, France, Infrastructure & Utilities, Internet & Online, Technology

Tagged , , , , , , , , , , , , ,

Exeter Gears Up for Soapbox Science, Bringing Science to the Public and Promoting Gender Equality in STEM

Posted on 18, May 2023 by

(IN BRIEF) Soapbox Science is returning to Exeter for its 7th event, featuring 12 female scientists sharing their research with the public on June 10th. The initiative aims to bring science to the general public and challenge gender stereotypes in … Read the full press release →

Posted in Education, Science, Society, Technology, United Kingdom

Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , ,

University of Dundee researcher awarded prestigious fellowship for type 1 diabetes cure

Posted on 29, March 2023 by

(IN BRIEF) Dr James Cantley from the University of Dundee’s School of Medicine has been awarded a Senior Research Fellowship by the Type 1 Diabetes Grand Challenge. The £50m funding for the Grand Challenge was donated by the Steve Morgan … Read the full press release →

Posted in Awards, Healthcare, Management, News, Science, United Kingdom

Tagged , , , , , , , , , , , ,

Sanofi’s Acquisition of Provention Bio Expands Immune-Mediated Disease Portfolio

Posted on 14, March 2023 by

(IN BRIEF) Sanofi has agreed to acquire Provention Bio, a U.S.-based biopharmaceutical company focused on preventing and intercepting immune-mediated diseases, for $2.9 billion. The acquisition includes Provention Bio’s first-in-class therapy for type 1 diabetes, TZIELD, which was approved in the … Read the full press release →

Posted in Business, France, Healthcare, Management, News, Pharma & Biotech, Science

Tagged , , , , , , , , ,

12-month real-world achievements for Diabeloop’s Automated Insulin Delivery (AID):

Posted on 21, September 2022 by

4 million1 hours of hypoglycemia avoided Trust in the algorithm leads to fewer meal declarations Users report a significantly reduced mental load (PRESS RELEASE) PARIS, 21-Sep-2022 — /EuropaWire/ — Diabeloop, a leader in therapeutic AI applied to insulin delivery, reports … Read the full press release →

Posted in Denmark, France, Healthcare, News, Pharma & Biotech, Science, Sweden, Technology

Tagged , , , , , , , , , , , , , , , , , , ,

Diabeloop presents new real-life results of DBLG1® System: Confirmed improvement in Time In Range +18.4 percentage points; Reduction of time spent in hypoglycemia to only 0.9%

Posted on 28, April 2022 by

(PRESS RELEASE) PARIS, 28-Apr-2022 — /EuropaWire/ — ATTD 2022 – Diabeloop, pioneer in therapeutic artificial intelligence for diabetes management, presents today new results from a real-life cohort in Germany. The data show a constant improvement in Time In Range (70-180 … Read the full press release →

Posted in Artificial Intelligence (AI), Denmark, France, Healthcare, News, Pharma & Biotech, Science, Spain, Technology

Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

University of Exeter led research may be at the doorstep of finding a treatment for the common diabetes complication hypoglycaemia

Posted on 17, December 2021 by

(PRESS RELEASE) EXETER, 17-Dec-2021 — /EuropaWire/ — University of Exeter, a public research university in Exeter, Devon, South West England, United Kingdom, has announced that a research that it led together with Rigel Pharmaceuticals (NASDAQ: RIGL), a biotech firm dedicated … Read the full press release →

Posted in Education, Healthcare, News, Pharma & Biotech, Science, Technology, United Kingdom

Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

TeffLand Introduces New Line of Flour: Improving on Wheat’s Deficiencies With 30% More Vitality

Posted on 15, February 2019 by

(PRESS RELEASE) STOCKHOLM, 15-Feb-2019 — /EuropaWire/ — TeffLand has launched new lines of grain and flour for the popular Teff cereal. The new products maintain all of Wheat’s advantages and none of its disadvantages. Unlike its Wheat counterpart, Teff flours make … Read the full press release →

Posted in Agriculture, Food & Beverage, Healthcare, News, Retail, Sweden

Tagged , , , , , , , , , ,

Novartis announces EC approval for Tafinlar® (dabrafenib) in combination with Mekinist® (trametinib) for adjuvant treatment of BRAF V600 mutation-positive melanoma

Posted on 31, August 2018 by

Approval based on COMBI-AD study demonstrating greater than 50% reduction in risk of disease recurrence or death in stage III melanoma patients   More than 50% of stage III melanoma patients are likely to recur to stage IV during their lifetime … Read the full press release →

Posted in European Union, Healthcare, Pharma & Biotech, Switzerland

Tagged , , , , , , , ,

University of Liverpool to lead international research project to transform early detection of diabetic eye disease

Posted on 1, February 2018 by

LIVERPOOL, 01-Feb-2018 — /EuropaWire/ — Liverpool is to lead on a £1.15 million international research project to help transform early detection of diabetic eye disease in developing countries. Researchers from the University of Liverpool, St Paul’s Eye Unit at the Royal Liverpool University … Read the full press release →

Posted in Education, Healthcare, Science, Technology, United Kingdom

Tagged , , , , , ,

Sanofi’s Toujeo® met primary objective in the first head-to-head clinical trial comparing Toujeo with insulin degludec

Posted on 5, December 2017 by

First head-to-head randomized clinical trial comparing the efficacy and safety of Toujeo (insulin glargine 300 Units/mL) versus insulin degludec PARIS, 05-Dec-2017 — /EuropaWire/ — Sanofi’s Toujeo® met the primary study objective in the first large head-to-head clinical trial1, called BRIGHT study, … Read the full press release →

Posted in France, Healthcare, Pharma & Biotech, Technology

Tagged , , , ,

University of Exeter: Dr Kyle Wedgwood and Dr Eder Zavala with fellowships from the Medical Research Council (MRC)

Posted on 5, July 2017 by

EXETER, 05-Jul-2017 — /EuropaWire/ — Prestigious fellowships from the Medical Research Council (MRC) will help nurture the next generation of research excellence at the University of Exeter. Dr Kyle Wedgwood, a mathematician from the Centre for Biomedical Modelling and Analysis, and Dr Eder … Read the full press release →

Posted in Education, Science, Technology, United Kingdom

Tagged , , , ,

AstraZeneca announce FDA approval of once-daily Qtern for the treatment of type-2 diabetes

Posted on 3, March 2017 by

Qtern fixed-dose combination will provide an additional oral medicine option for patients taking Farxiga (dapagliflozin) to improve blood sugar level LONDON, 03-Mar-2017 — /EuropaWire/ — AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved once-daily Qtern (10mg … Read the full press release →

Posted in Healthcare, Pharma & Biotech, United Kingdom

Tagged , , , ,

Sanofi’s Soliqua™ 100/33 now available by prescription in U.S. for the treatment of adults with type 2 diabetes

Posted on 4, January 2017 by

PARIS, 04-Jan-2017 — /EuropaWire/ — Sanofi announced today that Soliqua™ 100/33 (insulin glargine 100 Units/mL & lixisenatide* 33 mcg/mL injection) is now available by prescription in U.S. pharmacies. Soliqua 100/33 is indicated for the treatment of adults with type 2 … Read the full press release →

Posted in France, Healthcare, Pharma & Biotech

Tagged , , , ,

Medtronic announced U.S. commercial availability of its MiniMed Connect mobile accessory for Android

Posted on 27, October 2016 by

MiniMed Connect Mobile Accessory Provides Easier and Better Access to Pump and CGM Data, Helping Optimize Therapy for Improved Glycemic Patterns DUBLIN, 27-Oct-2016 — /EuropaWire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced U.S. commercial availability of … Read the full press release →

Posted in Healthcare, Internet & Online, Ireland, Technology

Tagged , , , ,

Technical University of Munich scientists studied the metabolism of women with gestational diabetes after giving birth

Posted on 22, July 2016 by

MUNICH, 22-Jul-2016 — /EuropaWire/ — An interdisciplinary team of scientists at the Technical University of Munich (TUM) has studied the metabolism of women with gestational diabetes after giving birth. Along with partners at Helmholtz Zentrum München and the German Center for … Read the full press release →

Posted in Education, Germany, Healthcare, Science

Tagged , ,

Rising hypoglycaemia admissions in hospitals – University of Leicester Study

Posted on 20, July 2016 by

University of Leicester researchers lead study into rising hypoglycaemia admissions in hospitals LEICESTER, 20-Jul-2016 — /EuropaWire/ — Hospital admissions for a short-term and avoidable complication of diabetes have risen by 39 per cent in the last ten years, a new analysis … Read the full press release →

Posted in Education, Healthcare, Science, United Kingdom

Tagged , , ,

Albert-Ludwigs-Universität Freiburg: Microfluidic chip where more than 100 apidose-derived adult stem cell cultures can grow and divide developed

Posted on 18, July 2016 by

Platform works with minute quantities of liquid to grow cells and study their development FREIBURG, 18-Jul-2016 — /EuropaWire/ — A Freiburg-based research group has developed a microfluidic chip where more than one hundred apidose-derived adult stem cell cultures can grow and … Read the full press release →

Posted in Education, Germany, Healthcare, Science

Tagged , , , , , , , , , , , , , , ,

University of Cambridge / GSK: Human genetics can support the development of new therapies

Posted on 2, June 2016 by

An approach that could reduce the chances of drugs failing during the later stages of clinical trials has been demonstrated by a collaboration between the University of Cambridge and pharmaceutical company GlaxoSmithKline (GSK).  CAMBRIDGE, 02-Jun-2016 — /EuropaWire/ — The technique involves … Read the full press release →

Posted in Education, Healthcare, Science, United Kingdom

Tagged , , , ,

Medtronic announced the availability of new CareLink® iPro report called Pattern Snapshot for iPro2 Professional CGM system

Posted on 1, December 2015 by

Simplified Report Uses New Algorithms to Streamline Diabetes Data Interpretation for the Health Care Professional DUBLIN, 1-12-2015 — /EuropaWire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the availability of a new CareLink® iPro report called Pattern Snapshot … Read the full press release →

Posted in Healthcare, Ireland, Technology

Tagged , , ,

Novartis: updated data from study shows significant overall survival benefit for patients with aggressive form of melanoma when treated with Tafinlar® + Mekinist®

Posted on 29, September 2015 by

Phase III data showed median overall survival of 25.6 months in patients with BRAF+ V600E/K metastatic melanoma who received Tafinlar + Mekinist Tafinlar + Mekinist combination also demonstrated significant improvement in health-related quality of life vs vemurafenib monotherapy in this … Read the full press release →

Posted in Healthcare, Pharma & Biotech, Switzerland

Tagged , , ,

Novartis: study shows Afinitor® reduced the risk of progression in patients with advanced nonfunctional gastrointestinal and lung NET

Posted on 29, September 2015 by

In pivotal study, everolimus reduced risk of disease progression by 52%; showed 11.0-month median progression-free survival vs 3.9 months for placebo[1] Advanced, progressive, nonfunctional neuroendocrine tumors of GI or lung origin are rare forms of cancer with poor prognoses and … Read the full press release →

Posted in Healthcare, Pharma & Biotech, Switzerland

Tagged , , ,

Sanofi: LixiLan-L Phase III clinical trial met its primary endpoint in patients with type 2 diabetes treated with insulin glargine with or without metformin

Posted on 14, September 2015 by

LixiLan met primary endpoint showing superior reduction in HbA1c vs Insulin Glargine alone PARIS, 14-9-2015 — /EuropaWire/ —  Sanofi announced today that the LixiLan-L Phase III clinical trial met its primary endpoint in patients with type 2 diabetes treated with insulin glargine with … Read the full press release →

Posted in France, Healthcare, Pharma & Biotech, Science

Tagged , , , , ,

University of Southampton: Int’l researchers to trial the use of a combination of nutrients and probiotics before and during pregnancy in a bid to improve the health of mothers and their babies

Posted on 5, August 2015 by

SOUTHAMPTON, 5-8-2015 — /EuropaWire/ — Researchers in the United Kingdom (Southampton), Singapore and New Zealand (Auckland) from the EpiGen Global Research Consortium are to trial the use of a combination of nutrients and probiotics before and during pregnancy in a bid … Read the full press release →

Posted in Education, Healthcare, Science, Society, Technology, United Kingdom

Tagged , , , , , , , , , , , , ,

Intel, Cisco and Deutsche Telekom announce the 12 startups selected to join the next phase of the Challenge Up! startup initiative Program

Posted on 16, July 2015 by

BONN, 16-7-2015 — /EuropaWire/ — Intel, Cisco and Deutsche Telekom today announced the twelve startups selected to join the next phase of the Challenge Up! Program, a joint startup initiative organized by the three companies. The twelve teams will participate … Read the full press release →

Posted in Business, Germany, Management, Marketing, Small Business, Technology

Tagged , , , , , , , , , , , , , , ,

Novartis: Phase III study of Afinitor® shows significant extension of progression-free survival in advanced gastrointestinal or lung neuroendocrine tumors

Posted on 21, May 2015 by

Study in patients with advanced nonfunctional neuroendocrine tumors (NET) of gastrointestinal (GI) or lung origin met primary endpoint[1] Full results will be submitted for presentation at a major medical meeting; worldwide regulatory filings are planned for 2015 Afinitor is already … Read the full press release →

Posted in Healthcare, Pharma & Biotech, Switzerland

Tagged , , ,

University of Aberdeen: UK and US scientists made major step forward in understanding how the brain senses low glucose levels

Posted on 23, January 2015 by

For people suffering from diabetes, managing blood sugar can be like walking a tightrope – if too high they run the risk of serious long term complications such as blindness, kidney failure, limb gangrene and premature heart disease, but allow … Read the full press release →

Posted in Education, Healthcare, United Kingdom

Tagged , , , , ,

Novartis’s Signifor® LAR to treat patients with life-threatening hormonal disorder acromegaly receives FDA approval

Posted on 18, December 2014 by

Acromegaly is an endocrine disorder caused by elevated growth hormone (GH) and insulin-like growth factor-1 (IGF-1) levels[1] Signifor LAR, a next-generation somatostatin analog, provides a new option for patients with acromegaly with inadequately controlled disease[2] Signifor LAR FDA approval is … Read the full press release →

Posted in Healthcare, Pharma & Biotech, Science, Switzerland

Tagged , , , , , ,

ETH Zurich researchers developed implantable acid sensor capable to control insulin production

Posted on 19, August 2014 by

Zürich, 19-8-2014 — /EuropaWire/ — ETH Zurich researchers from the Department of Biosystems Science and Engineering (D-BSSE) in Basel have developed an implantable device that precisely monitors acid build-up in the body for people with diabetes and produces insulin if acidosis becomes … Read the full press release →

Posted in Healthcare, Pharma & Biotech, Switzerland, Technology

Tagged , ,

AstraZeneca and Bristol-Myers Squibb Company announce US FDA approved FARXIGA™ (dapagliflozin) for type 2 diabetes adult patients treatment

Posted on 15, January 2014 by

London, UK, 15-1-2014 — /EuropaWire/ — AstraZeneca and Bristol-Myers Squibb Company announced the US Food and Drug Administration (FDA) approved FARXIGA™ [far-SEE-ga] (dapagliflozin), a once-daily oral treatment indicated as an adjunct to diet and exercise to improve glycaemic control in adults with … Read the full press release →

Posted in Government, Healthcare, Pharma & Biotech, United Kingdom

Tagged , , , , , ,

University of Glasgow Researchers found South Asians need more exercise than white Europeans to reduce diabetes risk

Posted on 1, July 2013 by

1-7-2013 — /europawire.eu/ — South Asians may have to exercise more than white Europeans to achieve the same levels of fitness and reduce their risk of diabetes. Researchers at the University of Glasgow have found lower fitness levels in middle-aged men … Read the full press release →

Posted in Education, Healthcare, Science, Sports, United Kingdom

Tagged , , , , , , ,

SAVOR-TIMI-53 cardiovascular outcomes trial of ONGLYZA® results announced by AstraZeneca and Bristol-Myers Squibb

Posted on 20, June 2013 by

20-6-2013 — /europawire.eu/ — AstraZeneca and Bristol-Myers Squibb announced today top-line results of the Phase IV SAVOR-TIMI-53 (Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus) clinical trial of Onglyza ® (saxagliptin). In this study of adult patients with … Read the full press release →

Posted in Healthcare, Pharma & Biotech, Science, United Kingdom

Tagged , , , , , , , , , , , , , , , , , , , , , , , , ,

Phase III data in The Lancet show significant benefit of Novartis drug Afinitor® in patients with non-cancerous tumors associated with TSC

Posted on 11, January 2013 by

More than 40% of TSC patients on everolimus had their kidney tumor volume reduced by at least half with no tumor progression[1] Separate data show 35% of TSC patients treated with everolimus had their SEGA brain tumor volume reduced by … Read the full press release →

Posted in Healthcare, Pharma & Biotech, Science, Switzerland

Symrise Unveils Novel Health Solutions at Vitafoods Europe 2024

Posted on 25, April 2024 by

(IN BRIEF) Symrise is set to debut innovative health active solutions at Vitafoods Europe 2024, showcasing six concepts designed to address gut health, immunity, healthy aging, and metabolic health. The company’s focus on consumer needs drives the development of these … Read the full press release →

Posted in Business, Food & Beverage, Germany, Healthcare, Industrial, Management, Media, News, Science, Technology

Tagged , , , , , , ,

Roche’s OCREVUS Subcutaneous Injection Shows Promise in Phase III Study for Multiple Sclerosis Treatment

Posted on 12, October 2023 by

(IN BRIEF) Roche has announced positive late-breaking data from the Phase III OCARINA II study, which demonstrates the effectiveness of OCREVUS as a twice-yearly, 10-minute subcutaneous injection for patients with relapsing or primary progressive multiple sclerosis (RMS or PPMS). The … Read the full press release →

Posted in Business, Education, Healthcare, Industrial, Management, News, Pharma & Biotech, Science, Switzerland, Technology

Tagged , , , , , , ,

Experts Call for Early Intervention to Curb Childhood Obesity and Reduce Cardiovascular Disease Risk in Adulthood

Posted on 27, July 2023 by

(IN BRIEF) A scientific statement published in the European Journal of Preventive Cardiology highlights that childhood obesity is a critical factor leading to cardiovascular disease (CVD) in adulthood. Childhood obesity is on the rise globally, and the associated problems of … Read the full press release →

Posted in Food & Beverage, France, Government, Healthcare, Law, Management, News

Tagged , , , , , ,